Table 2.
Univariate analysis | Multivariate analysis | |||
OR (95% CI) | p value | OR (95% CI) | p value | |
Age | 1.00 (0.99–1.01) | 0.329 | 0.99 (0.97–1.01) | 0.283 |
Sex (male) | 0.99 (0.75–1.30) | 0.923 | 1.08 (0.66–1.76) | 0.773 |
Ultrasound interval | 0.97 (0.96–0.99) | 0.001 | 0.95 (0.93–0.96) | 0.001 |
Alcohol consumption history | 0.61 (0.43–0.86) | 0.005 | 0.47 (0.28–0.78) | 0.004 |
NYHA class III–IV | 0.43 (0.31–0.59) | 0.001 | 0.28 (0.15–0.52) | 0.001 |
Coronary heart disease | 1.53 (1.18–1.99) | 0.001 | 0.98 (0.58–1.63) | 0.938 |
Dilated cardiomyopathy | 0.47 (0.33–0.65) | 0.001 | 0.47 (0.26–0.84) | 0.012 |
Hypertension | 1.69 (1.31–2.19) | 0.001 | 1.53 (1.02–2.29) | 0.040 |
Diabetes | 1.54 (1.16–2.04) | 0.003 | 0.94 (0.60–1.48) | 0.794 |
-blockers | 1.53 (1.17–2.00) | 0.002 | 2.29 (1.54–3.43) | 0.001 |
Uric acid | 0.998 (0.997–0.999) | 0.001 | 0.999 (0.997–1.000) | 0.046 |
PDW | 0.94 (0.89–0.99) | 0.026 | 1.07 (0.98–1.16) | 0.141 |
PCT | 16.64 (2.92–98.13) | 0.002 | 20.02 (0.89–510.93) | 0.065 |
Abbreviations: NYHA, New York Heart Association; PDW, platelet distribution width; PCT, plateletocrit; LVEF, left ventricular ejection fraction; OR, odds ratio; CI, confidence interval.